Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and Nembutal
Determining the interaction of Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and Nembutal and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Methylene blue may enhance the effects of PENTobarbital on the central nervous system. You may experience increased drowsiness, dizziness, difficulty concentrating, and incoordination. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid driving or operating hazardous machinery until you know how the medications affect you. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Limited clinical data suggest that nonselective monoamine oxidase inhibitors (MAOIs) may enhance or prolong the central nervous system effects of barbiturates. The mechanism of interaction is unknown, but may involve inhibition of barbiturate metabolism by MAOIs. Somnolence, dizziness, ataxia, and semi-consciousness have been reported.
MANAGEMENT: Until more information is available, patients should be monitored for increased barbiturate effects during coadministration with an MAOI or other agents that possess MAOI activity such as furazolidone, linezolid, methylene blue, and procarbazine.
- Sjoqvist F "Psychotropic drugs (2) interaction between monoamine oxidase (MAO) inhibitors and other substances." Proc R Soc Med 58 (1965): 967-78
- Domino EF, Sullivan TS, Luby ED "Barbiturate intoxication in a patient treated with a MAO inhibitor." Am J Psychiatry 118 (1962): 941-3
- Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate
Generic Name: pentobarbital
Brand name: Nembutal, Nembutal Sodium
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Nembutal Sodium injection
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Neo DM
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Neo-Fradin
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Neo-Metric
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Neo-Poly-Bac
- Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic-Neo-Poly-Dex
- Nembutal-Hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium phosphate
- Nembutal-Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate
- Nembutal-Hyosophen
- Nembutal-Hyosyne
- Nembutal-Hyosyne Elixir
- Nembutal-Hypaque